Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: Books Puddle, New York, NY, USA
Zustand: New.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 84,44
Anzahl: 4 verfügbar
In den WarenkorbZustand: New.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 83,25
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 92 pages. 8.66x5.91x0.21 inches. In Stock.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. A Nano delivery Approach: Development of Atorvastatin Nanoformulation | Rita Kalsyan (u. a.) | Taschenbuch | 92 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9783330062467 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 154,01
Anzahl: 1 verfügbar
In den Warenkorbpaperback. Zustand: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing Mrz 2017, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -As we aware that Atorvastatin is BCS (Class II) drug and has poor solubility, extreme first pass metabolism and thus has poor bioavailability; on keeping in mind of all that factors we have to select that route which minimize all these effects and such formulation which deliver the drug to brain as much as possible. Hence we select intranasal route it offers direct access of drug to brain through olfactory route and avoid first pass metabolism and is suitable to deliver drugs via nanoformulation and have previously been utilized for enhanced brain delivery. NLC formulation could be able to deliver atorvastatin conveniently by intranasal route. NLC are nano sized delivery systems used to deliver drugs via intranasal route in different disease conditions. Their utility in intranasal route has been well documented. They can be suitably modified for improved retention and can cross mucosal barrier. 92 pp. Englisch.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: moluna, Greven, Deutschland
EUR 41,71
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Kalsyan RitaRita Kalsyan: ICP, Greater Noida, India.Anil K Sahdev and Vinit Raj:Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow 226025, India.As we aware that Ato.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing Mär 2017, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -As we aware that Atorvastatin is BCS (Class II) drug and has poor solubility, extreme first pass metabolism and thus has poor bioavailability; on keeping in mind of all that factors we have to select that route which minimize all these effects and such formulation which deliver the drug to brain as much as possible. Hence we select intranasal route it offers direct access of drug to brain through olfactory route and avoid first pass metabolism and is suitable to deliver drugs via nanoformulation and have previously been utilized for enhanced brain delivery. NLC formulation could be able to deliver atorvastatin conveniently by intranasal route. NLC are nano sized delivery systems used to deliver drugs via intranasal route in different disease conditions. Their utility in intranasal route has been well documented. They can be suitably modified for improved retention and can cross mucosal barrier.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 92 pp. Englisch.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330062460 ISBN 13: 9783330062467
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - As we aware that Atorvastatin is BCS (Class II) drug and has poor solubility, extreme first pass metabolism and thus has poor bioavailability; on keeping in mind of all that factors we have to select that route which minimize all these effects and such formulation which deliver the drug to brain as much as possible. Hence we select intranasal route it offers direct access of drug to brain through olfactory route and avoid first pass metabolism and is suitable to deliver drugs via nanoformulation and have previously been utilized for enhanced brain delivery. NLC formulation could be able to deliver atorvastatin conveniently by intranasal route. NLC are nano sized delivery systems used to deliver drugs via intranasal route in different disease conditions. Their utility in intranasal route has been well documented. They can be suitably modified for improved retention and can cross mucosal barrier.